OSCR
Healthcare Plans · Healthcare
CTO, Board Member
2012-01-01–present
Board Member
Duolingo, Inc. (DUOL)Board Member
Oscar Health, Inc. (OSCR)Equibles does not estimate personal net worth.
Get an email with a short summary when Duolingo, Inc. publishes a filing, an earnings call transcript or a press release.
Get DUOL alertsMario Schlosser is recorded as Board Member at Duolingo, Inc. (DUOL), Board Member at Oscar Health, Inc. (OSCR) since January 1, 2012 and CTO at Oscar Health, Inc. (OSCR). The newest filing on record that lists Mario Schlosser as Board Member at Duolingo, Inc. (DUOL) is dated April 17, 2026. The newest filing on record that lists Mario Schlosser as CTO and Board Member at Oscar Health, Inc. (OSCR) is dated April 22, 2026. Oscar Health, Inc. reported in an 8-K filed June 2, 2026 that Mario Schlosser was appointed Co-Founder & Advisor to the CEO, effective June 1, 2026. Duolingo, Inc. reported in an 8-K filed June 21, 2024 that Mario Schlosser was appointed Class I director, effective July 1, 2024. The proxy statement of Oscar Health, Inc. reports total compensation of $7,314,572 for Mario Schlosser in fiscal 2025, including a base salary of $600,000. Disclosed compensation is on record for 6 fiscal years. Mario Schlosser has spoken on 8 earnings calls across 1 company, most recently for Oscar Health, Inc. on February 9, 2023. Oscar Health, Inc. is classified in the Healthcare Plans industry within the Healthcare sector. Duolingo, Inc. is classified in the Software - Application industry within the Technology sector. Other leadership on record at Oscar Health, Inc. includes Mark T. Bertolini (CEO and Board Member), Joshua Kushner (Chairman and Board Member), R. Scott Blackley (CFO and CTO) and 7 others.
“On May 29, 2026, Oscar Health, Inc. and Oscar Management Corporation (together, the "Company") and Mario Schlosser entered into an amended and restated employment agreement (the "A&R Employment Agreement"), effective as of June 1, 2026 (the "Effective Date"), in connection with Mr. Schlosser's transition from President of Technology and Chief Technology Officer of the Company to Co-Founder & Advisor to the CEO.”
“On June 14, 2024, the Board of Directors (the "Board") of Duolingo, Inc. (the "Company") appointed Mario Schlosser to serve as a Class I director on the Company's Board to fill the vacancy created from Ms. Laela Sturdy's departure, effective as of July 1, 2024.”
“Before we get to fourth quarter and full year 2022 results, I would like to provide some context on our story to date. For the past five years, we have seen a 75% compound annual growth rate for Direct and Assumed Policy Premiums.”
“I will provide updates on several topics, including our financial results for the quarter, our outlook on open enrollments and recent market dynamics, our strategy for a profitable insurance business in 2023, and more detail on the news updates that we shared earlier today.”
“Today, Oscar is serving more members and clients across the healthcare system than ever before. I'm proud of how our products are making healthcare more affordable and accessible for so many.”
“As usual, we will provide you today with a look into our financial results for the first quarter of 2022. Before we get into that, I want to remind you of why we think Oscar is well positioned in the evolving U.S. healthcare system.”
“We have created something unique here at Oscar. We entered 2022 with strong tailwinds in our business, and a clear strategy set for the years ahead. Building on our record-breaking growth, we remain focused on scaling operations and driving towards profitability.”
SEC 8-K
2026-06-01–present
2012-01-01–present
Last confirmed April 22, 2026
Start not stated–present
Last confirmed April 17, 2026
Start not stated–present
Last confirmed April 22, 2026
Start not stated–2022-04-26
Last confirmed by a filing; no departure on record
OSCR
Healthcare Plans · Healthcare
CTO, Board Member
2012-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Oscar Health, Inc. (OSCR) | President of Technology and Chief Technology Officer | $600,000 | $7,314,572 |
| 2024 | Oscar Health, Inc. (OSCR) | President of Technology and Chief Technology Officer | $600,000 | $10,847,822 |
| 2023 | Oscar Health, Inc. (OSCR) | President of Technology and Chief Technology Officer | $600,000 | $854,000 |
| 2022 | Oscar Health, Inc. (OSCR) | President of Technology and Chief Technology Officer | $495,681 | $652,405 |
| 2021 | Oscar Health, Inc. (OSCR) | Former Chief Executive Officer | $430,000 | $60,814,546 |
| 2020 | Oscar Health, Inc. (OSCR) | Former Chief Executive Officer | $493,750 | $564,449 |